Plasmapheresis Device Market (2019- 2026) | Global Industry Size, Share, Upcoming Trends, Business Growth, Competitive Landscape and Forecast to 2026
Global Plasmapheresis Devices Market
Plasmapheresis is a process in which the liquid part of the blood, or plasma, is separated from the blood cells. Typically, the plasma is replaced with another solution, such as saline or albumin, and in certain cases, the plasma is treated and then returned to the body. This procedure is carried out with the purpose of treating a wide range of autoimmune diseases, such as myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, sickle cell anemia, guillain-barre syndrome, and lambert-eaton myasthenic syndrome, which promote the growth of auto-antibodies causing harm to the body. Thus, plasmapheresis helps inhibit this growth of auto-antibodies by removing the plasma containing antibodies and replacing it with new, fresh plasma. Plasmapheresis can be performed using a semipermeable membrane-based device, in combination with hemodialysis equipment.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/2259
Global Plasmapheresis Devices Market Dynamics
Strategies used by the key market players, such as mergers & acquisitions, are expected to boost the growth of the global plasmapheresis devices market. For instance, in September 2018, Shire Plc. (SHP) acquired Sanaplasma AG, in an effort to expand its plasma collection network across Europe. This helped the company augment its customer base in the European region, which in turn, raised the demand for plasmapheresis devices in the region, thereby contributing to the global market growth.
In August 2018, Biotest Pharmaceuticals Corporation (BPC), a wholly-owned subsidiary of Biotest US Corporation, was acquired by Grifols Shared Services North America, Inc. The acquisition included 22 BPC plasma collection centers that provide critical care therapies to treat life-threatening disorders. Hence, this acquisition resulted in an increased availability of resources for plasma collections, as well as stimulated the demand for plasmapheresis devices globally.
However, stringent regulatory norms, and government permissions to the companies involved in plasma exchange and collection, are significant aspects expected to hamper the growth of the global market. As per an article published in Neurology India 2017, there is a dire need for procuring and periodically renewing permissions and licenses from regulatory authorities for providing plasma exchange.
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2259
Global Plasmapheresis Devices Market – Regional Analysis
The North America region is expected to dominate the global plasmapheresis device market, owing to the high prevalence of autoimmune diseases in the region that require frequent plasmapheresis tests. According to the American Autoimmune Related Diseases Association’s 2017 report, around 50 million Americans are suffering from autoimmune disorders each year.
The European region is expected to witness a substantial growth rate due to the rising penetration of plasmapheresis devices into the region. For instance, in October 2016, Fresenius Kabi, a company based in Germany, got FDA approval for its Aurora Xi Plasmapheresis System. The device is designed to improve the process of blood plasma collection, particularly speeding up the filtration process and allowing for more donors to donate in the same timeperiod.
Global Plasmapheresis Devices Market – Competitive Landscape
The key players operating in the global plasmapheresis devices market are Asahi Kasei Corporation., Terumo Corporation, Baxter International Inc., B. Braun Melsungen AG, Kawasumi Laboratories Inc., Kaneka Corporation, Haemonetics Corporation, Shanghai Dahua Medical Apparatus Co., Ltd., Infomed SA, and Fresenius SE & Co. KGaA.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/plasmapheresis-device-market-2259
By Product Type,
- Membrane Filtration
- Source Plasma Collection
- Therapeutic Plasmapheresis
By End User,
- Diagnostics Laboratories
- Biotech and Pharma Companies
- North America
- Asia Pacific
- Latin America
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire